![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Mylan Pharmaceuticals launches Fenofibrate Capsules
Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg. ...
Drug Research
Ablynx inks deal with Spirogen to evaluate novel anti-cancer drug conjugate
Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a novel anti-cancer drug conjugate. As...
Drug Research
UCB, ConfometRx sign drug discovery research deal
Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery of new drugs. Under the...
Drug Research
Dr. Reddy’s introduces Desloratadine ODT in US
Dr. Reddy's Laboratories has received the FDA approval and introduced Desloratadine orally disintegrating tablets (ODT) in 2.5mg and 5mg strengths in the US....
Drug Research
Stellar Biotechnologies develops aquaculture system for KLH manufacturing
Stellar Biotechnologies has developed a controlled, commercial-scale aquaculture system for fully sustainable Keyhole Limpet Hemocyanin (KLH) manufacturing. The land-based...
Drug Research
Synthon opens new GMP antibody-drug conjugate production facility in Nijmegen
Synthon Biopharmaceuticals has opened a GMP antibody-drug conjugate (ADC) production facility in Nijmegen. The Nijmegen facility will produce ADCs,...
Drug Research
Paladin introduces grass pollen allergy medication in Canada
Specialty pharmaceutical company Paladin Labs has introduced first allergen immunotherapy tablet, Oralair, against grass pollen allergies in Canada. The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read